ClinicalTrials.gov
ClinicalTrials.gov Menu

Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00044304
Recruitment Status : Recruiting
First Posted : August 26, 2002
Last Update Posted : April 4, 2018
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 1, 2026
  Estimated Study Completion Date : January 1, 2026
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):